Pilot Study for Metabolic Syndrome Intervention in the Emergency Department

This study is testing a new approach to help people with metabolic syndrome (MetS), a group of conditions like high blood pressure (hypertension), high blood sugar (hyperglycemia), and unhealthy cholesterol levels (dyslipidemia), who are also obese or overweight. The intervention includes an educational video, an exercise plan with a goal of 150 minutes of walking per week, a Fitbit device, healthy eating resources, text message reminders, and referrals to primary care. Researchers want to see if this approach is practical and effective. You might be able to join if you are an adult (18 years or older) visiting the emergency department, have a BMI of 30 kg/m2 or higher, and have at least one other MetS condition. The main goal is to see if participants increase their daily steps over a three-month period. This study is currently unclear on its recruitment status and plans to enroll 20 participants.

Study design
This is an interventional pilot study where 20 participants will be randomly assigned to either receive the intervention or usual care.
What's involved
Participants will wear a Fitbit Charge device on their wrist for the duration of the 3-month study period. The intervention group will also watch a short educational video.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed from enrollment to the end of the 3-month study period to measure mean daily steps.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07119658

Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial

Completed
NAAges 18+InterventionalTreatment
Indiana University
~20 participants
Updated 2026-08-19 on ClinicalTrials.gov
What's tested:Composite intervention to address MetS

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mean daily steps
Measured over From enrollment to the end of the 3 month study period
Hypertension
Hyperglycemia
Dyslipidemia
Metabolic Syndrome
Obesity &Amp; Overweight
Diabetes
Hyperlipidemia
Emergency Medicine
1 sites across 1 states
Indiana1

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Ambulatory adults (18 years of age) presenting to the emergency department setting
BMI 30 kg/m2
Prior diagnosis of at least one additional comorbid component of metabolic syndrome: hypertension, hyperglycemia, dyslipidemia
Clinical plan for discharge

Exclusion

Age \<18 years
Pregnant patients
Unable to safely ambulate (including patient or family perception of inability to safely ambulate)
Lack of access to smart phone
Unable or unwilling to wear Fitbit accelerometer device
Unable to obtain informed consent
  • Mean daily stepsFrom enrollment to the end of the 3 month study period

    Investigators will collect activity data utilizing a Fitbit accelerometer device. The primary outcome will be the mean number of daily steps averaged from 3 months of monitoring, compared between groups.